UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
Our findings underscore the significant role of UGCG in the chemoresistance and progression of breast cancer, suggesting it as a predictive biomarker and potential therapeutic target to combat chemoresistance in this disease.
Authors
- Dan Luo (ORCID: https://orcid.org/0000-0001-9621-7252)
- Qifeng Yang (ORCID: https://orcid.org/0000-0003-0576-8513)
- Yuhan Jin (ORCID: https://orcid.org/0000-0002-2887-053X)
- Dianwen Han
- Fangzhou Ye (ORCID: https://orcid.org/0000-0001-9630-2334)
- Yiran Liang (ORCID: https://orcid.org/0000-0002-2404-0408)
- Long Li (ORCID: https://orcid.org/0000-0003-0358-3099)
- Lei Wang (ORCID: https://orcid.org/0000-0001-5024-0238)
- Bing Chen (ORCID: https://orcid.org/0000-0003-0168-8532)
- Yajie Wang (ORCID: https://orcid.org/0000-0001-5042-0909)
- Xiaoyan Li (ORCID: https://orcid.org/0000-0003-1910-2464)
- Wenjing Zhao (ORCID: https://orcid.org/0000-0003-4477-596X)
- Lijuan Wang (ORCID: https://orcid.org/0000-0001-5944-3453)
- Yaming Li (ORCID: https://orcid.org/0000-0001-6754-9194)
Institutions
- Mianyang Central Hospital (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1016/j.tranon.2024.102241
- Citations
- 6
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.70